View Financial HealthPharma-Bio Serv 配当と自社株買い配当金 基準チェック /26Pharma-Bio Serv配当を支払う会社であり、現在の利回りは13.89%です。主要情報13.9%配当利回り0.3%バイバック利回り総株主利回り14.2%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 20, 2025Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about March 20, 2025 to shareholders of record at the close of business on February 28, 2025.お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share payable on or about February 15, 2024, to shareholders of record at the close of business on January 30, 2024.お知らせ • Dec 21Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a special dividend of $0.075 per share for Shareholders. The special dividend will be payable on or about February 15, 2024 to shareholders of record at the close of business on January 30, 2024.お知らせ • Feb 15Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 15, 2022Pharma-Bio Serv, Inc.'s Board of Directors approved a special dividend of $0.075 per share to shareholders. The dividend is payable on or about March 15, 2022 to shareholders of record at the close of business on February 25, 2022.すべての更新を表示Recent updatesお知らせ • Apr 17Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2026Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2026. Location: at the law offices of akerman llp, at 1875 nw corporate boulevard, suite 275, fl 33431, boca raton United Statesお知らせ • Apr 22Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2025Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2025. Location: at the lawoffices of akerman llp, at 201 east las olas boulevard, suite 1800, florida 33301, lauderdale, United Statesお知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 20, 2025Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about March 20, 2025 to shareholders of record at the close of business on February 28, 2025.お知らせ • Apr 09Pharma-Bio Serv, Inc., Annual General Meeting, May 02, 2024Pharma-Bio Serv, Inc., Annual General Meeting, May 02, 2024, at 10:00 Eastern Daylight. Location: the law offices of Akerman LLP at 201 East Las Olas Boulevard, Suite 1800, Ft. Lauderdale Florida United States Agenda: To consider the election of two (2) directors as Class II directors to serve for a term until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified; to consider the ratification of the selection of Crowe PR PSC as the Company’s independent certified public accountants for the fiscal year ending October 31, 2024; to consider the transaction of such other and further business as may properly come before the meeting or any, adjournments or postponements of the meeting.お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share payable on or about February 15, 2024, to shareholders of record at the close of business on January 30, 2024.お知らせ • Dec 21Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a special dividend of $0.075 per share for Shareholders. The special dividend will be payable on or about February 15, 2024 to shareholders of record at the close of business on January 30, 2024.お知らせ • May 28Pharma-Bio Serv, Inc., Annual General Meeting, Jun 23, 2022Pharma-Bio Serv, Inc., Annual General Meeting, Jun 23, 2022, at 10:00 US Eastern Standard Time. Location: the law offices of Akerman LLP at 201 East Las Olas Blvd., Suite 1800, Fort Lauderdale, Florida 33301 Florida United States Agenda: To elect of one (1) director as Class III director to serve for a term until the 2025 Annual Meeting of Stockholders or until his successor is duly elected and qualified; to consider the ratification of the selection of Crowe PR PSC as the Company’s independent certified public accountants for the fiscal year ending October 31, 2022; A non-binding advisory vote on the compensation of the named executive officers of the Company (“Say on Pay”); and to consider other matters if any.お知らせ • Feb 15Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 15, 2022Pharma-Bio Serv, Inc.'s Board of Directors approved a special dividend of $0.075 per share to shareholders. The dividend is payable on or about March 15, 2022 to shareholders of record at the close of business on February 25, 2022.お知らせ • May 08U.S. District Court for the District of Puerto Rico Enters Judgment Dismissing with Prejudice All Claims Brought Against Pharma-Bio Serv, Inc. and Pharma-Bio Serv PR, IncOn April 30, 2021, the U.S. District Court for the District of Puerto Rico entered judgment dismissing with prejudice all claims brought against Pharma-Bio Serv, Inc. (the Company) and the company's wholly-owned subsidiary, Pharma-Bio Serv PR, Inc., (Pharma PR) as previously disclosed in the Company's Quarterly Report on Form 10-Q for the period ended January 31, 2021, which was filed on March 17, 2021. In connection with the dismissal, plaintiff agreed not to file separate claims against the officers or directors of the Company or Pharma PR.お知らせ • Feb 02Pharma-Bio Serv, Inc. announced delayed annual 10-K filingOn 02/01/2021, Pharma-Bio Serv, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jan 12Pharma-Bio Serv, Inc. Announces the Resignation of Elizabeth Plaza as DirectorOn January 7, 2021, Elizabeth Plaza resigned as a director of Pharma-Bio Serv, Inc., effective immediately.お知らせ • Jan 06Pharma-Bio Serv, Inc. Appoints Kirk Michel as Chairman of the Board of DirectorsPharma-Bio Serv, Inc. announced the appointment of Kirk Michel as Chairman of the Board of Directors, effective January 4, 2021. Mr. Michel has served as a director of the company since January 2006.決済の安定と成長配当データの取得安定した配当: PBSVは 10 年未満配当金を支払っており、この間、支払額は 変動性 が高かった。増加する配当: PBSVは7年間のみ配当金を支払っており、それ以降支払額は増加していません。配当利回り対市場Pharma-Bio Serv 配当利回り対市場PBSV 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (PBSV)13.9%市場下位25% (US)1.4%市場トップ25% (US)4.3%業界平均 (Life Sciences)0.8%アナリスト予想 (PBSV) (最長3年)n/a注目すべき配当: PBSVの配当金 ( 13.89% ) はUS市場の配当金支払者の下位 25% ( 1.44% ) よりも高くなっています。高配当: PBSVの配当金 ( 13.89% ) はUS市場 ( 4.32% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: PBSVの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: PBSVは配当金を支払っていますが、同社にはフリーキャッシュフローがありません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 01:53終値2026/05/12 00:00収益2026/01/31年間収益2025/10/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Pharma-Bio Serv, Inc. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Jack WallaceSidoti & Company, LLCBradley SorensenZacks Small-Cap ResearchElizabeth SenkoZacks Small-Cap Research
お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 20, 2025Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about March 20, 2025 to shareholders of record at the close of business on February 28, 2025.
お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share payable on or about February 15, 2024, to shareholders of record at the close of business on January 30, 2024.
お知らせ • Dec 21Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a special dividend of $0.075 per share for Shareholders. The special dividend will be payable on or about February 15, 2024 to shareholders of record at the close of business on January 30, 2024.
お知らせ • Feb 15Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 15, 2022Pharma-Bio Serv, Inc.'s Board of Directors approved a special dividend of $0.075 per share to shareholders. The dividend is payable on or about March 15, 2022 to shareholders of record at the close of business on February 25, 2022.
お知らせ • Apr 17Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2026Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2026. Location: at the law offices of akerman llp, at 1875 nw corporate boulevard, suite 275, fl 33431, boca raton United States
お知らせ • Apr 22Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2025Pharma-Bio Serv, Inc., Annual General Meeting, May 15, 2025. Location: at the lawoffices of akerman llp, at 201 east las olas boulevard, suite 1800, florida 33301, lauderdale, United States
お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 20, 2025Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about March 20, 2025 to shareholders of record at the close of business on February 28, 2025.
お知らせ • Apr 09Pharma-Bio Serv, Inc., Annual General Meeting, May 02, 2024Pharma-Bio Serv, Inc., Annual General Meeting, May 02, 2024, at 10:00 Eastern Daylight. Location: the law offices of Akerman LLP at 201 East Las Olas Boulevard, Suite 1800, Ft. Lauderdale Florida United States Agenda: To consider the election of two (2) directors as Class II directors to serve for a term until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified; to consider the ratification of the selection of Crowe PR PSC as the Company’s independent certified public accountants for the fiscal year ending October 31, 2024; to consider the transaction of such other and further business as may properly come before the meeting or any, adjournments or postponements of the meeting.
お知らせ • Jan 31Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a Special Dividend of $0.075 per share payable on or about February 15, 2024, to shareholders of record at the close of business on January 30, 2024.
お知らせ • Dec 21Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024Pharma-Bio Serv, Inc. announced that the Board of Directors approved a special dividend of $0.075 per share for Shareholders. The special dividend will be payable on or about February 15, 2024 to shareholders of record at the close of business on January 30, 2024.
お知らせ • May 28Pharma-Bio Serv, Inc., Annual General Meeting, Jun 23, 2022Pharma-Bio Serv, Inc., Annual General Meeting, Jun 23, 2022, at 10:00 US Eastern Standard Time. Location: the law offices of Akerman LLP at 201 East Las Olas Blvd., Suite 1800, Fort Lauderdale, Florida 33301 Florida United States Agenda: To elect of one (1) director as Class III director to serve for a term until the 2025 Annual Meeting of Stockholders or until his successor is duly elected and qualified; to consider the ratification of the selection of Crowe PR PSC as the Company’s independent certified public accountants for the fiscal year ending October 31, 2022; A non-binding advisory vote on the compensation of the named executive officers of the Company (“Say on Pay”); and to consider other matters if any.
お知らせ • Feb 15Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 15, 2022Pharma-Bio Serv, Inc.'s Board of Directors approved a special dividend of $0.075 per share to shareholders. The dividend is payable on or about March 15, 2022 to shareholders of record at the close of business on February 25, 2022.
お知らせ • May 08U.S. District Court for the District of Puerto Rico Enters Judgment Dismissing with Prejudice All Claims Brought Against Pharma-Bio Serv, Inc. and Pharma-Bio Serv PR, IncOn April 30, 2021, the U.S. District Court for the District of Puerto Rico entered judgment dismissing with prejudice all claims brought against Pharma-Bio Serv, Inc. (the Company) and the company's wholly-owned subsidiary, Pharma-Bio Serv PR, Inc., (Pharma PR) as previously disclosed in the Company's Quarterly Report on Form 10-Q for the period ended January 31, 2021, which was filed on March 17, 2021. In connection with the dismissal, plaintiff agreed not to file separate claims against the officers or directors of the Company or Pharma PR.
お知らせ • Feb 02Pharma-Bio Serv, Inc. announced delayed annual 10-K filingOn 02/01/2021, Pharma-Bio Serv, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jan 12Pharma-Bio Serv, Inc. Announces the Resignation of Elizabeth Plaza as DirectorOn January 7, 2021, Elizabeth Plaza resigned as a director of Pharma-Bio Serv, Inc., effective immediately.
お知らせ • Jan 06Pharma-Bio Serv, Inc. Appoints Kirk Michel as Chairman of the Board of DirectorsPharma-Bio Serv, Inc. announced the appointment of Kirk Michel as Chairman of the Board of Directors, effective January 4, 2021. Mr. Michel has served as a director of the company since January 2006.